WASHINGTON — The Association for Accessible Medicines (AAM) announced today that its board of directors has named David Gaugh as interim chief executive officer.

A trained pharmacist and longtime pharmaceutical industry veteran, Gaugh has been in leadership at AAM for a decade where his accomplishments as head of its Sciences and Regulatory Affairs department include leading the effort to successfully authorize and then reauthorize two successive multi-billion-dollar user fee agreements for the generics and biosimilars industry with the Food and Drug Administration.